Consolidated Statements of Shareholders' Equity - USD ($) $ in Millions	Total	Common Stock	Additional Paid-In Capital	Retained Earnings	Treasury Stock, Common	Accumulated Other Comprehensive Loss
Shares balance beginning of period (in shares) at Jan. 01, 2022		223,000,000.0
Balance at beginning of period at Jan. 01, 2022	$ 3,735	$ 2	$ 2,970	$ 782		$ (19)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation expense	12		12
Proceeds from employee stock purchase plan (in shares)		200,000
Proceeds from employee stock purchase plan	5		5
Vested restricted stock units, net		700,000
Vested restricted stock units, net (in shares)		(200,000)
Exercise of stock options (in shares)		100,000
Exercise of stock options	2		2
Tax withholding payments for net share-settled equity awards	(16)		(16)
Series A convertible preferred stock dividends	(9)			(9)
Net income	(7)			(7)
Shares balance end of period (in shares) at Apr. 02, 2022		223,800,000
Balance at end of period at Apr. 02, 2022	3,722	$ 2	2,973	766		(19)
Shares balance beginning of period (in shares) at Jan. 01, 2022		223,000,000.0
Balance at beginning of period at Jan. 01, 2022	3,735	$ 2	2,970	782		(19)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Series A convertible preferred stock conversion to common stock	0
Unrecognized gain on interest rate caps, net of income tax	0
Net income	172
Shares balance end of period (in shares) at Oct. 01, 2022		224,800,000
Balance at end of period at Oct. 01, 2022	3,927	$ 2	3,017	927		(19)
Shares balance beginning of period (in shares) at Apr. 02, 2022		223,800,000
Balance at beginning of period at Apr. 02, 2022	3,722	$ 2	2,973	766		(19)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation expense	9		9
Proceeds from employee stock purchase plan (in shares)		200,000
Proceeds from employee stock purchase plan	7		7
Exercise of stock options (in shares)		300,000
Exercise of stock options	5		5
Series A convertible preferred stock dividends	(9)			(9)
Net income	70			70
Shares balance end of period (in shares) at Jul. 02, 2022		224,300,000
Balance at end of period at Jul. 02, 2022	3,804	$ 2	2,994	827		(19)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation expense	13		13
Proceeds from employee stock purchase plan	5		5
Exercise of stock options (in shares)		500,000
Exercise of stock options	5		5
Series A convertible preferred stock dividends	(9)			(9)
Unrecognized gain on interest rate caps, net of income tax	0
Net income	109			109
Shares balance end of period (in shares) at Oct. 01, 2022		224,800,000
Balance at end of period at Oct. 01, 2022	$ 3,927	$ 2	3,017	927		(19)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Treasury stock, common (in shares)	400,000				400,000
Shares balance beginning of period (in shares) at Dec. 31, 2022		225,200,000
Balance at beginning of period at Dec. 31, 2022	$ 3,961	$ 2	3,036	1,010	$ (14)	(73)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation expense	14		14
Proceeds from employee stock purchase plan (in shares)		200,000
Proceeds from employee stock purchase plan	5		5
Vested restricted stock units, net (in shares)		600,000
Exercise of stock options (in shares)		300,000
Exercise of stock options	7		7
Tax withholding payments for net share-settled equity awards	(11)		(11)
Series A convertible preferred stock conversion to common stock (in shares)		7,600,000
Series A convertible preferred stock dividends	(7)			(7)
Series A convertible preferred stock conversion to common stock	161		161
Unrecognized gain on interest rate caps, net of income tax	1					1
Common stock repurchased (in shares)					900,000
Common stock repurchased	(34)				$ (34)
Net income	82			82
Shares balance end of period (in shares) at Apr. 01, 2023		233,900,000
Balance at end of period at Apr. 01, 2023	4,179	$ 2	3,212	1,085	(48)	(72)
Shares balance beginning of period (in shares) at Dec. 31, 2022		225,200,000
Balance at beginning of period at Dec. 31, 2022	3,961	$ 2	3,036	1,010	(14)	(73)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Series A convertible preferred stock conversion to common stock	534
Unrecognized gain on interest rate caps, net of income tax	1
Excise tax on common stock repurchases	(2)
Net income	359
Shares balance end of period (in shares) at Sep. 30, 2023		252,500,000
Balance at end of period at Sep. 30, 2023	4,692	$ 3	3,642	1,362	$ (245)	(70)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Treasury stock, common (in shares)					1,300,000
Shares balance beginning of period (in shares) at Apr. 01, 2023		233,900,000
Balance at beginning of period at Apr. 01, 2023	4,179	$ 2	3,212	1,085	$ (48)	(72)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation expense	14		14
Proceeds from employee stock purchase plan (in shares)		200,000
Proceeds from employee stock purchase plan	8		8
Vested restricted stock units, net (in shares)		100,000
Exercise of stock options (in shares)		700,000
Exercise of stock options	15		15
Series A convertible preferred stock conversion to common stock (in shares)		17,400,000
Series A convertible preferred stock conversion to common stock	373	$ 1	372
Unrecognized gain on interest rate caps, net of income tax	1					1
Common stock repurchased (in shares)					4,200,000
Common stock repurchased	(166)				$ (166)
Excise tax on common stock repurchases	(2)				(2)
Net income	182			182
Shares balance end of period (in shares) at Jul. 01, 2023		252,300,000
Balance at end of period at Jul. 01, 2023	4,604	$ 3	3,621	1,267	$ (216)	(71)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Treasury stock, common (in shares)					5,500,000
Share-based compensation expense	15		15
Proceeds from employee stock purchase plan (in shares)		200,000
Proceeds from employee stock purchase plan	6		6
Unrecognized gain on interest rate caps, net of income tax	1					1
Common stock repurchased (in shares)					700,000
Common stock repurchased	(29)				$ (29)
Net income	95			95
Shares balance end of period (in shares) at Sep. 30, 2023		252,500,000
Balance at end of period at Sep. 30, 2023	$ 4,692	$ 3	$ 3,642	$ 1,362	$ (245)	$ (70)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Treasury stock, common (in shares)	6,200,000				6,200,000